GlassScriptPhysician profile
Craig A Ternovits
NPI 1063520666
$16,859.03
in general payments reported to CMS, 2019-2025
12 companies · $5,637 in 2025
The $5,637 reported for 2025 was more than what 91% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $195 · 2020: $44.20 · 2021: $57.03 · 2024: $11K · 2025: $5,637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $9,000 · Travel and Lodging: $5,533 · Food and Beverage: $2,015 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $9,000.00 |
| Travel and Lodging | $5,532.65 |
| Food and Beverage | $2,015.37 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $16,167.60 | 2019-2025 | |
| Davol INC. | $259.14 | 2025 | Phasix Mesh |
| W. L. Gore & Associates, INC. | $147.35 | 2024 | Gore Synecor Biomaterial, Seamguard Staple Line Reinforcement |
| Smith+Nephew, INC. | $50.67 | 2024-2025 | Pico 14, Pico, Collagenase Santyl |
| Ethicon US, LLC | $42.72 | 2021-2025 | Endopath |
| Tela Bio, INC. | $36.26 | 2024 | Ovitex 2s |
| Braintree Laboratories, INC. | $33.94 | 2020-2021 | |
| Becton, Dickinson and Company | $30.48 | 2024 | Bard 3dmax Mesh |
| Acell, INC. | $24.27 | 2020 | |
| Tempus Ai, INC | $22.68 | 2024 | |
| Olympus America INC. | $22.65 | 2019 | |
| Bolton Medical INC | $21.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Ternovits listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.